Literature DB >> 8989794

Sedation and analgesia for minor pediatric procedures.

J T Algren1, C L Algren.   

Abstract

Owing to recent emphasis upon the benefits of effective pain management, parents and health care providers expect infants and children to receive safe, effective sedation and analgesia for diagnostic and therapeutic procedures. The Committee on Drugs of the American Academy of Pediatrics has addressed the issue of safety in its recently revised guidelines for monitoring and management of patients undergoing sedation for procedures. Patients undergoing emergency procedures present additional problems because of the limited opportunity to optimally prepare patients and families. Today, managing children undergoing invasive procedures can include the use of sedatives, analgesics, anesthetics, and nonpharmacologic strategies. New formulations of local and topical anesthetics have enhanced their efficacy and reduced pain associated with administration. Innovations in the administration of sedatives and analgesics, as well as antagonists, have enhanced both efficacy and safety. This article reviews recommended guidelines for monitoring and management of patients undergoing sedation for minor procedures and discusses various sedative, analgesic, and anesthetic alternatives available to clinicians.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8989794     DOI: 10.1097/00006565-199612000-00013

Source DB:  PubMed          Journal:  Pediatr Emerg Care        ISSN: 0749-5161            Impact factor:   1.454


  2 in total

1.  Emergency analgesia in the paediatric population. Part III non-pharmacological measures of pain relief and anxiolysis.

Authors:  J J O'Donnell; S C Maurice; T F Beattie
Journal:  Emerg Med J       Date:  2002-05       Impact factor: 2.740

2.  Comparing Two Different Doses of Intravenous Midazolam in Pediatric Sedation and Analgesia.

Authors:  Hassan Barzegari; Kambiz Masoumi; Hassan Motamed; Behzad Zohrevandi; Shima Zeynadini Meymand
Journal:  Emerg (Tehran)       Date:  2016-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.